Microplastic particles (MPs, <5 mm) can be detected worldwide in air, water, soil and food and have become established in almost all human organs. Initial studies have shown the presence of MPs in the blood, placenta, lungs and urinary tract. In male patients, MPs have already been described in semen and testicular tissue, which raises the question of whether MPs also accumulate in prostate tissue and what effects this could have on carcinogenesis.
Autoren
- Tanja Schliebe
Publikation
- Urologie-Special
Related Topics
You May Also Like
- An emerging interface with clinical relevance
Lung cancer and neuroscience
- Acute leukemia: Disease management
Priorities from the perspective of patients and family caregivers
- Bronchodilators for asthma
The early bird … gasps for air
- Chronic kidney disease (CKD)
Triage of high-risk patients – Update 2025
- AAD Annual Meeting: Review
HS and acne – what’s new?
- New perspectives for the optimization of cancer immunotherapy
Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9
- Past, present and future
Biomarkers in schizophrenia
- From genome profiles to targeted therapies